Please login to the form below
anxiety
This page shows the latest anxiety news and features for those working in and with pharma, biotech and healthcare.
Sage’s postpartum depression treatment Zulresso gains US approval
Unlike conventional antidepressants, which can take weeks to kick in, the single infusion starts working within 2-3 days of dosing and can lift women quickly out of the sadness, anxiety,
Latest news
-
Sage raises $575m ahead of FDA review date for Zulresso
Unlike conventional antidepressants, which can take weeks to kick in, Zulresso starts working within two to three days of dosing and can lift women quickly out of the sadness, anxiety, irritability,
-
BMS isn’t phased by Opdivo’s slowing growth – for now
Lung cancer filing withdrawn after FDA reservations. Bristol-Myers Squibb’s fourth-quarter results showed a healthy sales increase for immuno-oncology blockbuster Opdivo, but there are signs that anxiety is
-
Moderna CEO makes case for firm’s lofty valuation
Moderna’s record-breaking $604m IPO last year was followed by a steep decline in its shares, which contributed to the anxiety about biotech sector financing overall in 2019, although Bancel
-
AstraZeneca wins NICE backing for asthma injection
hold them back from doing many basic daily tasks, lead to psychological problems including anxiety and depression, and leave them in constant fear of a potentially lethal asthma attack.
-
After December slump, what’s in store for biotech in 2019?
Analysts say 2019 could be a "big year for proceeds if not for deal count"
More from news
Approximately 1 fully matching, plus 142 partially matching documents found.
Latest Intelligence
-
Changing healthcare communications
Replacing anxiety with confidence, mediocrity with purpose. By David Hunt and Lou Shipley. ... But only if we replace anxiety with confidence, mediocrity with purpose, and attract the brightest, smartest and most creative minds to join our cause.
-
Drug launches to watch in 2019
There were also significant improvements for AbbVie’s drug over Humira on quality of life measures and over Stelara on anxiety and depression, and risankizumab did better than both comparator drugs
-
AstraZeneca’s oncology renaissance
Galbraith is concerned about the rise in reported anxiety and mental health problems in young people, with young women most vulnerable.
-
The Patient Safety Challenge
There were anxieties about how reporting could affect their reputations and career prospects.
-
Finding the patient voice
This data provided the big picture about what motivates people to join clinical trials, their anxieties and their experiences. ... we should communicate with them, depending on their needs and anxieties.
More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.
Latest appointments
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
5 Ways to Communicate With Millennials About Healthcare
Being transparent adds authenticity, builds trust, and eases some anxieties that come with making important health decisions.
-
Artificial Intelligence in Healthcare
Stoking the fires of both patients’ and healthcare professionals’ (HCP) anxiety regarding the implementation of such a monumental system change are the hordes of drug makers who are beating on the
-
World Diabetes Day: Interaction and impact of diabetes on mental health
A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabetic medicine, 25(9), pp.1096-1101.
-
Neurodiversity, ADHD and work: Obstacles and opportunities
they generally persist through to adulthood, leading to on average worse educational, occupational, economic, social and relationship outcomes,[3] with higher rates of comorbidities such as mood, anxiety and sleep
-
Apple Watch Series 4: A life-saving tool or just making us more health obsessed?
I was once told that health anxiety (often known as hypochondriasis) is one of the most common types of anxiety. ... by its wearers in a negative fashion - instilling fear and anxiety in many.
More from PMHub
Approximately 0 fully matching, plus 20 partially matching documents found.
Featured jobs
- Senior Account Manager, Medical Communications, London
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Scientific Director – Medical Communications
-
Salary TBC
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Health Consultant - Brand Comms
-
Competitive Salary
-
Account Director, Medical Education
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
Subscribe to our email news alerts
- Fishawack acquires Dudnyk
- GSK’s myeloma drug hits target, prompting rapid filing pledge
- Winners of the HSJ Partnership Awards 2019 unveiled
- 50 questions for delivering an exceptional healthcare brand experience
- Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity
- The brand strategy revolution
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- 50 questions for delivering an exceptional healthcare brand experience
- Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
- The brand strategy revolution
- Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
